Chimeric antibodies

N/A

Report date: 2024/11/07 20:00:06

Base Information

Drug NameChimeric antibodies
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSoft Tissue Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMoonshot Antibodies
China Registration ClassN/A

Develop Information

Active CompaniesMoonshot Antibodies
Inactive CompaniesN/A
Active IndicationsSoft Tissue Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A